Press Releases

According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General Meeting 2025 shall be composed of members appointed by the three largest shareholders as of September...

Sedana Medical AB (publ) plans to present its interim report for the third quarter of 2024 on Thursday October 24 at 13:30 CET. According to the financial calendar, Sedana Medical plans to publish the interim report for the third quarter 2024 on Thursday...

Second quarter 2024 January-June 2024 CEO comments We continue to focus on our ambitious goals for 2024: achieving an all-time-high in sales, reaching EBITDA break-even outside of the US during the year, and progressing towards our single biggest growth...

“I am excited about acquiring Innovatif Cekal as this transaction is a perfect fit with our strategy. After streamlining our non-customer-facing functions and implementing a vigorous shift of resources towards the frontline, this strategic move...

According to the financial calendar, Sedana Medical plans to publish the interim report for the second quarter 2024 on Tuesday July 23 at approximately 07.00 CET. Sedana Medical hereby invites to a presentation of the report on the same day, where the...

“The completion of INSPiRE-ICU 2 concludes Sedana Medical´s clinical trials in the United States. Running this study together with esteemed clinical investigators from highly ranked academic centers such as Columbia, the Harvard-affiliated...

Regarding full details of the resolutions, referral is made to the notice convening the general meeting and the complete proposals. The notice convening the general meeting and the complete proposals are available at the company’s website, http://www.sedanamedical.com...

First quarter 2024 CEO comments Off to a strong start with record sales in Q1 Coming out of a successful 2023, we have established ambitious goals for 2024: achieving an all-time-high in sales, attaining EBITDA break-even outside of the US within the...

“The completion of the INSPiRE-ICU 1 study marks a true milestone for Sedana Medical. Launching the randomized controlled multicenter studies across the large and diverse US healthcare landscape, in mixed surgical and medical ICUs with a different...

NOTICE OF ANNUAL GENERAL MEETING IN SEDANA MEDICAL AB (PUBL) The annual general meeting of Sedana Medical AB (publ) will be held on Wednesday, 22 May 2024 at 2:00 pm at Vendevägen 89, Danderyd. Registration begins at 1:30 pm. RIGHT TO ATTEND AND...